A new strategy — an injectable antibody — for lowering blood lipids and thereby potentially preventing coronary artery disease and other conditions caused by the build - up of fats, cholesterol, and other
substances on the artery walls, is supported by findings from two new studies from researchers in the Perelman School of Medicine at the University of Pennsylvania.